Volume 31, Issue 6 e13736
ORIGINAL ARTICLE

New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)-experience from an Italian oncology network

Anna Crispo

Anna Crispo

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Giorgia Rivieccio

Giorgia Rivieccio

Department of Managerial Studies and Quantitative Methods, University of Naples Parthenope Faculty of Economics, Naples, Italy

Search for more papers by this author
Luca Cataldo

Luca Cataldo

Department of Managerial Studies and Quantitative Methods, University of Naples Parthenope Faculty of Economics, Naples, Italy

Search for more papers by this author
Sergio Coluccia

Sergio Coluccia

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Assunta Luongo

Assunta Luongo

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Elisabetta Coppola

Elisabetta Coppola

Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS ‘Fondazione G. Pascale’, Naples, Italy

Search for more papers by this author
Maria Grimaldi

Maria Grimaldi

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Concetta Montagnese

Corresponding Author

Concetta Montagnese

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Correspondence

Concetta Montagnese and Assunta Luongo, Epidemiology and Biostatistics Unit, National Cancer Institute IRCCS Pascale Foundation, Via Mariano Semmola s.n.c., 80131 Naples, Italy.

Email: [email protected] and [email protected]

Search for more papers by this author
Flavia Nocerino

Flavia Nocerino

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Davide D'Errico

Davide D'Errico

Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS ‘Fondazione G. Pascale’, Naples, Italy

Search for more papers by this author
Egidio Celentano

Egidio Celentano

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Rocco Saviano

Rocco Saviano

National Cancer Institute IRCCS Pascale Foundation, Naples, Italy

Search for more papers by this author
Anna Bastone

Anna Bastone

Department of Managerial Studies and Quantitative Methods, University of Naples Parthenope Faculty of Economics, Naples, Italy

Search for more papers by this author
Giovanni Baglio

Giovanni Baglio

AGENAS - Italian National Agency for Regional Healthcare Services, Rome, Italy

Search for more papers by this author
Carmine De Angelis

Carmine De Angelis

Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy

Search for more papers by this author
Fortunato Ciardiello

Fortunato Ciardiello

Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania ‘L. Vanvitelli’, Naples, Italy

Search for more papers by this author
Antonio Avallone

Antonio Avallone

Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Antonino Cassata

Antonino Cassata

Medical Oncology Unit, Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Raffaele Costanzo

Raffaele Costanzo

Thoracic Department, Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Alessandro Morabito

Alessandro Morabito

Thoracic Department, Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Paolo Maione

Paolo Maione

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy

Search for more papers by this author
Cesare Gridelli

Cesare Gridelli

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy

Search for more papers by this author
Silvio Cigolari

Silvio Cigolari

Hospital Health Direction, Azienda Ospedaliera Universitaria ‘San Giovanni di Dio e Ruggi d'Aragona’, Salerno, Italy

Search for more papers by this author
Anna Borrelli

Anna Borrelli

Hospital Health Direction, Azienda Ospedaliera Universitaria ‘San Giovanni di Dio e Ruggi d'Aragona’, Salerno, Italy

Search for more papers by this author
Sabino De Placido

Sabino De Placido

Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy

Search for more papers by this author
Francesco Schiavone

Francesco Schiavone

Department of Managerial Studies and Quantitative Methods, University of Naples Parthenope Faculty of Economics, Naples, Italy

Search for more papers by this author
Attilio A. M. Bianchi

Attilio A. M. Bianchi

Directorate-General for Management, Istituto Nazionale Tumori 'Fondazione G. Pascale', Naples, Italy, Naples, Italy

Search for more papers by this author
Sandro Pignata

Sandro Pignata

Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS ‘Fondazione G. Pascale’, Naples, Italy

Search for more papers by this author
ValPeROC Group
First published: 25 October 2022

Funding information:

5x1000 project titled ‘Valutazione percorso rete oncologica campana ValPeROC’, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy; BMS Bristol Meyer Squibb; Astrazeneca.

[Correction added on 2 November 2022, after first online publication: The author Davide D'Errico was added in this version.]

Abstract

Objective

The primary goal of the Campania Oncology Network (ROC) was to reduce cancer delay and care fragmentation through the establishment of cancer-specific multidisciplinary oncologic groups (GOMs) and diagnostic and therapeutic assistance paths (PDTAs).

Methods

Five cancer centres of the ROC, with their own cancer specific GOM, were selected. In our analysis, we have focused on four neoplasms: lung, colon, ovarian and prostate cancers. The median time for pre-GOM and GOM Times was calculated for each tumour site. Univariate and multivariate logistic regressions were performed to individuate risk factors for pre-GOM and GOM Time.

Results

Significant differences were observed for prostate cancer compared to other patients either for pre-GOM or GOM Times. Significant risks were found for ovarian and prostate cancers in pre-GOM time and for prostate cancer in GOM-Time.

Conclusions

This experience will produce knowledge and data to guide decision-making and to manage more effectively the challenges of fighting cancer in Campania region. The Valutazione Percorso Rete Oncologica Campana (ValPeROC) study evaluates, for the first time, the ROC activity, through the analysis of key performance indices. Pre-GOM and GOM Time represent the quality of the entire regional health system and are useful to define models, which can evaluate the performance of the ROC over time.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

DATA AVAILABILITY STATEMENT

The data presented in this study are openly available in Zenodo at https://doi.org/10.5281/zenodo.6322994

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.